Algenesis Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $5M

  • Investors
  • 20

Algenesis General Information

Description

Operator of a material science and technology company intended to manufacture renewable, and biodegradable plastic material from algae. The company develops biodegradable polyurethane foam products which consist of soft foams for footwear and hard foams for surfboards, enabling companies to address the global plastic pollution crisis by redesigning plastic material.

Contact Information

Formerly Known As
Arctic Technologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Materials
Other Industries
Footwear
Corporate Office
  • 1238 Sea Village Drive
  • Cardiff, CA 92007
  • United States
+1 (206) 000-0000

Algenesis Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Algenesis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Seed Round 26-Oct-2023 $5M 000.00 Completed Generating Revenue
13. Accelerator/Incubator 01-Jul-2023 000.00 Completed Generating Revenue
12. Grant 000 000.00 Completed Generating Revenue
11. Later Stage VC (Series A) 08-May-2023 00.00 000.00 Completed Generating Revenue
10. Grant 01-Jan-2023 00.000 000.00 Completed Generating Revenue
9. Later Stage VC 11-Jul-2022 00000 000.00 Completed Generating Revenue
8. Grant 31-Dec-2021 00.000 000.00 Completed Generating Revenue
7. Grant 31-Aug-2021 00000 000.00 Completed Generating Revenue
6. Later Stage VC (Series 1) 16-Apr-2021 $2.37M $23.4M Completed Generating Revenue
5. Early Stage VC (Series B1) $21M $21M 0000 Completed Generating Revenue
To view Algenesis’s complete valuation and funding history, request access »

Algenesis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1 Convertible 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Algenesis’s complete cap table history, request access »

Algenesis Patents

Algenesis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230167225-A1 Degradable bio-based polymers Pending 27-Apr-2020 0000000000
EP-4143251-A1 Degradable bio-based polymers Pending 27-Apr-2020 00000000000
US-20230010722-A1 Biologically-derived fatty acids and polymers Pending 17-Oct-2019 00000000000
EP-4045667-A1 Biologically-derived fatty acids and polymers Pending 17-Oct-2019 00000000000
EP-4045667-A4 Biologically-derived fatty acids and polymers Pending 17-Oct-2019 C12P7/6409 0
To view Algenesis’s complete patent history, request access »

Algenesis Executive Team (6)

Name Title Board Seat Contact Info
Stephen Mayfield Ph.D Co-Founder, Chief Executive Officer & Board Member
Thomas Cooke President & Board Member
Peter Morgan Co-Founder & Chief Financial Officer
Michael Burkart Ph.D Co-Founder, Chairman, Scientific Advisory Board & Chief Scientist
Nick Sandland Chief Business Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Algenesis Board Members (7)

Name Representing Role Since
Daniel Dearen Self Board Member 000 0000
Daniel Rosen Self Board Member 000 0000
Jose Lozano Self Board Member & Advisor 000 0000
Nancy Dynan Algenesis Board Member 000 0000
Stephen Mayfield Ph.D Algenesis Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Algenesis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Algenesis Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Band of Angels Angel Group Minority 000 0000 000000 0
Better Bite Ventures Venture Capital Minority 000 0000 000000 0
Circulate Capital Impact Investing Minority 000 0000 000000 0
Diamond Sports Group Corporation Minority 000 0000 000000 0
E8 (Seattle) Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 20 investors. Get the full list »

Algenesis FAQs

  • When was Algenesis founded?

    Algenesis was founded in 2016.

  • Who is the founder of Algenesis?

    Stephen Mayfield Ph.D, Peter Morgan, Michael Burkart Ph.D, and Robert Pomeroy are the founders of Algenesis.

  • Who is the CEO of Algenesis?

    Stephen Mayfield Ph.D is the CEO of Algenesis.

  • Where is Algenesis headquartered?

    Algenesis is headquartered in Cardiff, CA.

  • What is the size of Algenesis?

    Algenesis has 18 total employees.

  • What industry is Algenesis in?

    Algenesis’s primary industry is Other Materials.

  • Is Algenesis a private or public company?

    Algenesis is a Private company.

  • What is Algenesis’s current revenue?

    The current revenue for Algenesis is 00000.

  • How much funding has Algenesis raised over time?

    Algenesis has raised $30.5M.

  • Who are Algenesis’s investors?

    Band of Angels, Better Bite Ventures, Circulate Capital, Diamond Sports Group, and E8 (Seattle) are 5 of 20 investors who have invested in Algenesis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »